Cortechs.ai | Revolutionizing Imaging Diagnostics with Cortechs.ai CEO, Kyle Frye

Revolutionizing Imaging Diagnostics with Cortechs.ai CEO, Kyle Frye

Cortechs.ai CEO Kyle Frye Featured on SCALE Community Healthcare Technology & Innovation Podcast

We’re excited to share that Kyle Frye, CEO of Cortechs.ai, recently sat down with the SCALE Community Healthcare Technology & Innovation Podcast for an insightful conversation about the future of medical technology. As a market leader and innovator in AI-powered solutions for neurology, radiology, and oncology, Cortechs.ai is transforming healthcare through advanced imaging technologies.

In this episode, Kyle dives into how Cortechs.ai leverages clinical data and machine learning to empower physicians with more accurate and timely diagnostic insights. Listeners will hear about the company’s pioneering advancements, such as their state-of-the-art imaging solutions that improve patient outcomes and streamline clinical workflows.

Key topics discussed include:

  • The impact of AI-powered quantitative MRI in transforming radiology
  • Innovative solutions for neuroimaging and prostate cancer diagnosis
  • How data-driven insights are revolutionizing the decision-making process for physicians
  • The company’s vision for continued innovation in healthcare technology

Don’t miss this engaging conversation with Kyle as he shares how Cortechs.ai is shaping the future of medical imaging and empowering healthcare professionals worldwide.

You can listen to the podcast on:

Tune in to discover how Cortechs.ai is advancing clinical care through cutting-edge technology!

More Resources

07/31/2025

Precision Without the Pressure: Smarter Brain Tumor Monitoring

Learn about NeuroQuant Brain Tumor 2.0 and how it assists clinicians by providing objective quantification and analysis of tumor changes over time.

07/30/2025

Cortechs.ai Announce Next-Gen NeuroQuant Brain Tumor: AI-Driven Metastasis & Meningioma Segmentation 

NeuroQuant Brain Tumor is the first FDA-cleared, cloud-native tool to offer automated volumetric segmentation for brain metastases, meningiomas, and gliomas.

07/28/2025

Longitudinal Assessment of Traumatic Brain Injury Using NeuroQuant®

A case study with Dr. Suzie Bash on NeuroQuant as a reliable, reimbursable, and efficient tool in the evaluation and follow-up of TBI.

07/24/2025

Understanding the Hippocampal Occupancy Score

One of the most frequently asked questions among customers is, “What does the Hippocampal Occupancy Score (HOC) represent within the Dementia Report?”

07/16/2025

Advancing Prostate MRI with Restriction Spectrum Imaging

Why is OnQ Prostate unique, and what makes it a game-changer for clinicians?

07/08/2025

Enhancing Neuroimaging Insights: LVV & ICV Quantification and Midline Shift Indexing with NeuroAlign CT

Time-sensitive and precise diagnostic imaging can mean the difference between rapid intervention and devastating outcomes.
Scroll to Top